Tuberculosis Infection and Latent Tuberculosis

Active tuberculosis (TB) has a greater burden of TB bacilli than latent TB and acts as an infection source for contacts. Latent tuberculosis infection (LTBI) is the state in which humans are infected with Mycobacterium tuberculosis without any clinical symptoms, radiological abnormality, or microbiological evidence. TB is transmissible by respiratory droplet nucleus of 1–5 μm in diameter, containing 1–10 TB bacilli. TB transmission is affected by the strength of the infectious source, infectiousness of TB bacilli, immunoresistance of the host, environmental stresses, and biosocial factors. Infection controls to reduce TB transmission consist of managerial activities, administrative control, engineering control, environmental control, and personal protective equipment provision. However, diagnosis and treatment for LTBI as a national TB control program is an important strategy on the precondition that active TB is not missed. Therefore, more concrete evidences for LTBI management based on clinical and public perspectives are needed.

keywords: Tuberculosis, Infection, Transmission, Infection Control, Latent Tuberculosis

Reference

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.

2. Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet 2016;387:1211-26.

3. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 2002;8:679-84.

4. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-6.

5. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.

6. Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis 1969;100:165- 71.

7. Riley RL, Mills CC, Nyka W, Weinstock N, Storey PB, Sultan LU, et al. Aerial dissemination of pulmonary tuberculosis: a two-year study of contagion in a tuberculosis ward. 1959. Am J Epidemiol 1995;142:3-14.

8. Reichman LB, Hershfield ES. Tuberculosis: a comprehensive international approach. 2nd ed. New York: Marcel Dekker Inc.; 2005.

9. Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol 1978;107:421- 32.

10.

10. Riley RL. Aerial dissemination of pulmonary tuberculosis. Am Rev Tuberc 1957;76:931-41.

11.

11. Ratcliffe HL, Palladino VS. Tuberculosis induced by droplet nuclei infection; initial homogeneous response of small mammals (rats, mice, guinea pigs, and hamsters) to human and to bovine bacilli, and the rate and pattern of tubercle development. J Exp Med 1953;97:61-8.

12.

12. Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis 2015;21:1913-20.

13.

13. Lee SH. Diagnosis and treatment of latent tuberculosis infection. Tuberc Respir Dis 2015;78:56-63.

14.

14. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.

15.

15. World Health Organization. WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva: World Health Organization; 2009.

16.

16. Ninomura P, Rousseau C, Bartley J. Updated guidelines for design and construction of hospital and health care facilities. ASHRAE J 2006;48:H33-7.

17.

17. Canadian Thoracic Society. Canadian tuberculosis standards. 7th ed. Ottawa: Canadian Thoracic Society; 2013.

18.

18. National Institute for Health and Clinical Excellence. Clinical guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control [Internet]. London: National Institute for Health and Clinical Excellence; 2011 [cited 2016 Apr 2]. Available from: http://www.nice.org.uk/CG117.

19.

19. Jindani A, Dore CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003;167:1348-54.

20.

20. National Tuberculosis Controllers Association; Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005;54:1-47.

21.

21. Joint Committee for the Revision of Korean Guidelines for Tuberculosis; Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2014.

22.

22. Allen EA. Tuberculosis and other mycobacterial infections of the lung. In: Thurbeck WM, Chung AM, editors. Pathology of the lung. 2nd ed. New York: Thieme Medical Publishers; 1995. p. 253-4.

23.

23. Elkington PT, Friedland JS. Permutations of time and place in tuberculosis. Lancet Infect Dis 2015;15:1357-60.

24.

24. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc 1970;26:28-106.

25.

25. Brooks-Pollock E, Becerra MC, Goldstein E, Cohen T, Murray MB. Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru. J Infect Dis 2011;203:1582-9.

26.

26. Esmail H, Barry CE 3rd, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci 2014;369:20130437.

27.

27. Ryu YJ. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms. Tuberc Respir Dis 2015;78:64- 71.

바로가기메뉴

Article Contents

Vol.79 No.4

Tuberculosis Infection and Latent Tuberculosis

Abstract

Reference

Tuberculosis & Respiratory Diseases